Scrip: industry news and insights
Novartis Holds Out For Happier Second Half Of 2020
By Kevin Grogan 26 Jan 2021
The fourth quarter proved to be challenging for Novartis, with its dermatology, ophthalmology and oncology products – and Zolgensma –...